Stock AMV AMERICAN VIETNAMESE BIOTECH INCORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Financials American Vietnamese Biotech Incorporation

Equities

AMV

VN000000AMV5

Pharmaceuticals

End-of-day quote HANOI S.E.
Other stock markets
 03:30:00 03/05/2024 am IST 		5-day change 1st Jan Change
3,200 VND 0.00% Intraday chart for American Vietnamese Biotech Incorporation 0.00% -17.95%
01/02 American Vietnamese Biotech Incorporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
01/02 American Vietnamese Biotech Incorporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019
Capitalization 1 10,30,398 9,30,070
Enterprise Value (EV) 1 9,53,166 9,67,467
P/E ratio 4.79 x 4.23 x
Yield - 11.4%
Capitalization / Revenue 2.29 x 1.91 x
EV / Revenue 2.11 x 1.99 x
EV / EBITDA 4.23 x 4.15 x
EV / FCF - 60,37,215 x
FCF Yield - 0%
Price to Book 2.12 x 1.26 x
Nbr of stocks (in thousands) 53,147 53,147
Reference price 2 19,388 17,500
Announcement Date 09/04/20 09/04/20
1VND in Million2VND
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019
Net sales 1 4,50,796 4,87,382
EBITDA 1 2,25,304 2,33,313
EBIT 1 2,22,645 2,26,982
Operating Margin 49.39% 46.57%
Earnings before Tax (EBT) 1 2,19,663 2,24,676
Net income 1 2,15,098 2,19,842
Net margin 47.72% 45.11%
EPS 2 4,047 4,137
Free Cash Flow - 1,60,251
FCF margin - 32.88%
FCF Conversion (EBITDA) - 68.68%
FCF Conversion (Net income) - 72.89%
Dividend per Share - 2,000
Announcement Date 09/04/20 09/04/20
1VND in Million2VND
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019
Net Debt 1 - 37,397
Net Cash position 1 77,232 -
Leverage (Debt/EBITDA) - 0.1603 x
Free Cash Flow - 1,60,251
ROE (net income / shareholders' equity) - 32.9%
ROA (Net income/ Total Assets) - 18.6%
Assets 1 - 11,80,590
Book Value Per Share 2 9,157 13,835
Cash Flow per Share 2 1,611 201.0
Capex 1 50,244 67,656
Capex / Sales 11.15% 13.88%
Announcement Date 09/04/20 09/04/20
1VND in Million2VND
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
AMERICAN VIETNAMESE BIOTECH INCORPORATION Stock American Vietnamese Biotech Incorporation
-17.95% 16.52M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.08% 681B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+21.85% 556B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.77% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 325B
ABBVIE INC. Stock AbbVie Inc.
+5.69% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 235B
NOVARTIS AG Stock Novartis AG
+3.65% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-11.12% 189B
PFIZER, INC. Stock Pfizer, Inc.
-3.40% 157B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. AMV Stock
  4. Financials American Vietnamese Biotech Incorporation